BlackRock Advisors’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-164,523
| Closed | -$2.93M | – | 3687 |
|
|
2015
Q1 | $2.93M | Hold |
164,523
| – | – | ﹤0.01% | 1070 |
|
|
2014
Q4 | $3.03M | Sell |
164,523
-5,675
| -3% | -$104K | ﹤0.01% | 1059 |
|
|
2014
Q3 | $4.12M | Sell |
170,198
-9,238
| -5% | -$224K | ﹤0.01% | 994 |
|
|
2014
Q2 | $6.55M | Buy |
179,436
+161
| +0.1% | +$5.88K | 0.01% | 879 |
|
|
2014
Q1 | $8.21M | Hold |
179,275
| – | – | 0.01% | 842 |
|
|
2013
Q4 | $6.97M | Sell |
179,275
-36,706
| -17% | -$1.43M | 0.01% | 892 |
|
|
2013
Q3 | $9.78M | Buy |
215,981
+31,420
| +17% | +$1.42M | 0.01% | 786 |
|
|
2013
Q2 | $9.06M | Buy |
+184,561
| New | +$9.06M | 0.01% | 806 |
|